不同治疗方式在甲状腺眼病初始期与慢性期的有效性:系统评价与Meta分析
该系统评价与Meta分析纳入26项研究,按甲状腺眼病病程分层,比较初始期(6个月内)与亚急性/慢性期启动治疗的疗效。初始期糖皮质激素和替妥木单抗可显著改善临床活动度评分、眼球突出和复视,亚急性/慢性期甲泼尼龙和替妥木单抗疗效降低,观察到「关键窗口」效应。作者强调应依据病程制定治疗策略并尽早干预。
要点
- 初始期糖皮质激素和替妥木单抗可显著改善临床活动度评分、眼球突出和复视。
- 亚急性/慢性期甲泼尼龙和替妥木单抗的疗效降低。
- 观察到「关键窗口」效应,甲状腺眼病病程超过6个月后治疗疗效减弱。
核心结论
- 该Meta分析强调应依据甲状腺眼病病程制定个体化治疗策略,重视早期干预以最大化获益,并指出需进一步研究以完善循证方法。
研究设计与样本
- 遵循PRISMA指南系统检索多个电子数据库,最终纳入26项符合预设纳入标准的研究,并评估方法学质量、提取和分析数据。
主要发现
- 初始期糖皮质激素和替妥木单抗在临床活动度评分、眼球突出和复视方面显示显著改善。
- 亚急性/慢性期甲泼尼龙和替妥木单抗的疗效降低。
- 观察到「关键窗口」效应,甲状腺眼病病程超过6个月后治疗疗效减弱。
关键数值与推荐
- 初始期定义为甲状腺眼病病程前6个月内启动治疗,亚急性/慢性期为此后启动治疗。
临床怎么用
- 作者认为应依据甲状腺眼病病程制定治疗策略,强调早期干预以最大化获益,并指导临床医生选择最佳治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid eye disease (TED), a common extrathyroidal manifestation of Graves disease, poses significant management challenges due to potential disfigurement, visual impairment, and decreased quality of life. Uncertainties remain about the optimal treatment approach, especially regarding TED duration and its impact on outcomes. OBJECTIVE: This meta-analysis evaluates the effects of various treatments on inflammatory markers and severity endpoints in TED, stratified by disease duration, distinguishing between treatments initiated within the first 6 months (initial phase) and those initiated thereafter (subacute/chronic phase). METHODS: Following PRISMA guidelines, a systematic search of multiple electronic databases yielded 26 studies meeting predefined inclusion criteria. Methodological quality was assessed, and data were meticulously extracted and analyzed. RESULTS: In the initial phase, treatments like corticosteroids and teprotumumab showed significant improvements in clinical activity score, proptosis, and diplopia. In the subacute/chronic phase, the efficacy of methylprednisolone and teprotumumab is reduced. A "critical window" effect was observed, with treatments showing diminished efficacy after 6 months of TED duration. CONCLUSION: This meta-analysis highlights the importance of tailoring treatment strategies based on TED duration, emphasizing early interventions to maximize benefits. The findings guide clinicians in selecting optimal treatments and underscore the need for further research to refine evidence-based approaches, ultimately enhancing patient outcomes and quality of life.
引用
- Alves Junior JM, Bernardo W, Villagelin D, et al. Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review With Meta-analysis. J Clin Endocrinol Metab. 2024. PMID: 39076015. doi:10.1210/clinem/dgae526
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。